CHIT1 and metabolic dysfunction-associated steatohepatitis: Having established pharmacokinetic and pharmacodynamic properties of OATD-01 in rats and activity toward rat CHIT1 enzyme, we have moved towards efficacy assessment in the rat MASH model.